Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Heinzer

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Oncotarget|September 20, 2019
Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissuesSarah Bonk, Martina Kluth, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|August 6, 2019
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical ProstatectomySarah Minner, Dominik Hager, Stefan Steurer, et al.
Cancer Biology & Medicine|September 14, 2019
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of <i>PTEN</i> deleted prostate cancersAndreas M Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Oncotarget|September 20, 2019
Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissuesSarah Bonk, Martina Kluth, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|August 6, 2019
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical ProstatectomySarah Minner, Dominik Hager, Stefan Steurer, et al.
Cancer Biology & Medicine|September 14, 2019
Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of <i>PTEN</i> deleted prostate cancersAndreas M Luebke, Ali Attarchi-Tehrani, Jan Meiners, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Biomed Research International|November 16, 2020
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical RecurrenceSimon Kind, Martina Kluth, Claudia Hube-Magg, et al.
Disease Markers|May 8, 2020
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate CancerAndreas Marx, Andreas M Luebke, Till S Clauditz, et al.
Neoplasia (New York, N.Y.)|June 24, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomyNatalia Gorbokon, Seyma Büyücek, Henning Plage, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Pageof 15